41 studies found for:    " May 28, 2008":" June 27, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting Effectiveness of Antiretroviral Therapy During Acute HIV Infection
Condition: HIV Infections
Interventions: Drug: Highly Active Antiretroviral Therapy (HAART);   Other: No treatment
22 Terminated Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility
Conditions: Candidiasis;   HIV Infections
Intervention:
23 Completed Sleep Quality and Presence of Sleep Disordered Breathing
Conditions: HIV Infections;   Sleep
Intervention:
24 Completed VENICE Study Nevirapine Full Dose/Dose Escalation
Condition: HIV Infections
Intervention: Drug: nevirapine
25 Unknown  The Detection of Drug-Resistant HIV-1 in Taiwan
Condition: HIV Infections
Intervention:
26 Completed Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks
Condition: HIV Infections
Interventions: Behavioral: Network leader training;   Behavioral: Standard HIV risk-reduction counseling
27 Completed Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Emtricitabine/tenofovir disoproxil fumarate placebo;   Drug: Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate placebo;   Drug: Tenofovir 1% vaginal gel;   Drug: Tenofovir placebo
28 Active, not recruiting Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations
Condition: HIV Infections
Interventions: Behavioral: Face-to-face training;   Behavioral: Distance training;   Behavioral: Popular Opinion Leader (POL)
29 Completed
Has Results
Kaletra-isentress Treatment Evaluation
Condition: HIV Infections
Interventions: Drug: Kaletra + Isentress;   Drug: Pre-study antiretroviral regimen
30 Completed Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.
Condition: Tuberculosis (TB)
Interventions: Biological: GSK's candidate Mycobacterium tuberculosis vaccine 692342;   Biological: Control vaccine with the adjuvant system.;   Biological: Control vaccine with physiological saline
31 Withdrawn Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring
Condition: HIV Infection
Intervention:
32 Completed Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc
Condition: HIV Infections
Intervention: Drug: Maraviroc
33 Completed
Has Results
Immune Responses to Pneumococcal Vaccination Among HIV-infected Subjects
Condition: HIV Infections
Interventions: Biological: (PV) 23-valent pneumococcal polysaccharide vaccine;   Biological: Placebo
34 Completed Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects
Conditions: HIV Infections;   Adverse Effects
Intervention: Behavioral: Cognitive-behavioral therapy
35 Withdrawn Surveillance Cohort Long-Term Toxicity Antiretrovirals in HIV-Infected Patients Enrolled in TPV Cohort
Condition: HIV Infections
Intervention: Drug: Tipranavir
36 Completed Registry to Assess Long-term Outcome in HIV Subjects Who Participated in Phase 2 and 3 Clinical Trials Involving Vicriviroc (Study P04999)
Condition: HIV Infections
Interventions: Drug: Vicriviroc maleate;   Drug: Placebo;   Drug: Emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
37 Completed Linkage to Care - Part I
Condition: HIV
Intervention:
38 Unknown  TDM of Generic Lopinavir/Ritonavir 200/50 mg
Condition: HIV
Intervention: Drug: generic lopinavir/ritonavir
39 Completed Study of Hepatitis C Virus (HCV) Viral Kinetics in HIV/HCV and HCV Patients
Condition: Hepatitis C
Intervention:
40 Terminated
Has Results
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
Condition: Kaposi's Sarcoma
Interventions: Drug: VEGF inhibitor PTC299;   Genetic: gene expression analysis;   Genetic: polymerase chain reaction;   Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: biopsy

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-41) Show next page of results
Indicates status has not been verified in more than two years